GlaxoSmithKline Shs Sponsored American Deposit Receipt Repr 2 Shs $48.03

down -0.17


29/7/2014 04:03 PM  |  NYSE : GSK  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get GSK Trend Analysis - it has underperformed the S&P 500 by 23%

Partner Headlines

  1. A Look at the Week's Top Dividend Growers

    GuruFocus
  2. Markets Little Changed Ahead Of The Federal Reserve's Policy Decision

    Benzinga
  3. GlaxoSmithKline

    IBD
  4. Stock Futures Up, But Wobbly; Boeing, Apple, Biogen Rising

    IBD
  5. Mylan Wins Motion To Enjoin GlaxoSmithKline From Providing Paroxetine CR ...

    Benzinga
  6. Morning Market Movers

    Benzinga
  7. Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Highest ...

    Benzinga
  8. Highest Yielding Stocks Widely Held By The Gurus

    GuruFocus
  9. British Stocks: Sweet Spot For European Value

    YCharts
  10. Diamond Hill Capital Comments on GlaxoSmithKline PLC

    GuruFocus
  11. ISIS Pharma Trades Up Premarket; NYT Says Has Potential Heart Attack Drug

    Benzinga
  12. Advances In HIV, Hep C Treatments Could Spark Renewed Interest In Biotech ...

    Benzinga
  13. InterMune Up On Bullish View Of U.S. Esbriet Launch

    IBD
  14. UPDATE: Glaxo, Theravance Report Positive Data from Two Studies Considering ...

    Benzinga
  15. Major British Companies Lead Top Guru-Held UK and Ireland Stocks

    GuruFocus
  16. ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?

    Benzinga
  17. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica & Targeted ...

    Benzinga
  18. Aura Of Light Shines On Pernix Shares Following Treximet Acquisition

    Benzinga
  19. Cross-Border Megamergers Drive Global Takeover Boom

    IBD
  20. Google Celebrates Dorothy Hodgkin & Her Contributions To Chemistry

    Benzinga
  21. Can Pfizer Make Up Its Loss?

    GuruFocus
  22. Merck Sells Consumer Unit To Bayer To Focus On R&D

    IBD
  23. Bayer Buys Merck Consumer Care Unit

    FoxBusiness
  24. AstraZeneca Rejects Pfizer's $106B Buyout Bid

    FoxBusiness
  25. #PreMarket Primer: Thursday, May 1: Fed Brushes Off Dissapointing GDP And ...

    Benzinga
  26. Glaxo hurt by Advair scandal

    IBD
  27. Nasdaq Leads Early Stock Slide; Twitter Tumbles, Trinity Rises

    IBD
  28. Stock Futures Slip as Traders Brace for Economic Flood

    FoxBusiness
  29. Disappointing GDP Reading Weighs on Stocks

    FoxBusiness
  30. China Rule Change Further Opens Yuan To World Markets

    IBD
  31. Weekly 52-Week Highs Highlight: AV, XEL, OKE, GSK

    GuruFocus
  32. GSK, MMV Announce Commencement of Phase III Programme of Tafenoquine for ...

    Benzinga
  33. These Three Pharmaceutical Companies Shake The Market With Their Deal

    GuruFocus
  34. Benzinga Weekly Preview: Earnings Season Continues As Biotech & Pharmaceutical ...

    Benzinga
  35. Big Pharmas Swap Specialties

    IBD
  36. Drugmakers Prod European Stocks To Post-Easter Rally

    IBD
  37. Valeant's Bid For Allergan Boosts Ethical Drug Stocks

    IBD
  38. Novartis, Glaxo Swap Units; Valeant Bids For Allergan

    IBD
  39. Stocks Rise In Higher Volume; Gilead Up After Hours

    IBD
  40. S&P 500, Nasdaq Rise For Sixth Day As Volume Picks Up

    IBD
  41. Pharma Deal Frenzy: A Bid to Boost Profits, Cut Risk

    FoxBusiness
  42. Amgen Slumps After 1Q Earnings Miss

    FoxBusiness
  43. Drug ETFs Surge On M&A Activity (AGN, VRX, IHE, XPH, PPH, AZN)

    Benzinga
  44. Novartis, Glaxo Swap Units; Lilly Buying Animal Biz

    IBD
  45. Stock Futures Mixed And Busy; Allergan, Netflix, Glaxo Climb

    IBD
  46. Novartis Announces Multi-Billion-Dollar Revamp

    FoxBusiness
  47. US Stock Futures Edge Higher Ahead Of McDonald's Earnings

    Benzinga
  48. Stock Futures Steady Amid Raft of Health M&A

    FoxBusiness
  49. Wall Street Ticks Up as Traders Parse News Deluge

    FoxBusiness
  50. GlaxoSmithKline Finally Received Approval from FDA for Its Diabetes Drug ...

    GuruFocus
Trading Center